Chen Xiaoxue, Zhao Zhigang, Zhao Rui, Li Wenjing, Liu Xinyu, Tian Linli, Liu Ming
Department of Otorhinolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Department of Otorhinolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Nangang District, Harbin, 150001, Heilongjiang Province, China.
Cancer Immunol Immunother. 2025 Jan 3;74(2):64. doi: 10.1007/s00262-024-03915-y.
Tumor-derived small extracellular vesicles (sEVs) play an essential role in reprogramming the tumor microenvironment. Metabolic reprogramming is an essential prerequisite for M2 polarization of tumor-associated macrophages (TAMs). This M2 phenotype is closely related to the immune dysfunction of CD8 T cells and subsequent tumor progression. This study evaluates the role of laryngeal squamous cell carcinoma cell-derived small extracellular vesicles (LSCC-sEVs) in M2 polarization of TAMs and CD8 T cell dysfunction, and delineates the underlying mechanisms.
Human leukemia monocyte cell line (THP-1) was induced to differentiate into M0 macrophages using phorbol 12-myristate 13-acetate. M0 macrophages were incubated with sEVs derived from LSCC cells TU212. CD8T cells, extracted from peripheral blood mononuclear cells of healthy volunteer donors, were co-cultured with the LSCC-sEV-treated M0 macrophages to evaluate their proliferation, and immune function. The role of LSCC-sEVs was investigated in macrophage tumor-bearing mouse models.
LSCC-sEVs promoted TAM M2 polarization and impaired CD8 T cell function, attributing to PD-L1 expression upregulation. In addition, suppression of metabolic reprogramming could partially reverse LSCC-sEV-induced CD8 T cell dysfunction. STC-1 was found highly enriched in LSCC-sEVs. Knockdown of STC1 abrogated metabolic reprogramming of TAMs into M2-like macrophages and restored CD8 T cell function. Importantly, in vivo results showed that LSCC-sEVs transform TAMs into M2 phenotype by mediating metabolic reprogramming and induce CD8 T cell dysfunction, ultimately accelerating tumor growth.
Our data reveal a previously undescribed role for LSCC-sEVs in the regulation of M2 polarization of TAMs and immune cell function through STC1 mediated metabolic reprogramming.
肿瘤来源的小细胞外囊泡(sEVs)在重塑肿瘤微环境中起着至关重要的作用。代谢重编程是肿瘤相关巨噬细胞(TAMs)M2极化的必要前提。这种M2表型与CD8 T细胞的免疫功能障碍及随后的肿瘤进展密切相关。本研究评估喉鳞状细胞癌细胞来源的小细胞外囊泡(LSCC-sEVs)在TAMs的M2极化和CD8 T细胞功能障碍中的作用,并阐明其潜在机制。
使用佛波酯诱导人白血病单核细胞系(THP-1)分化为M0巨噬细胞。将M0巨噬细胞与源自LSCC细胞TU212的sEVs一起孵育。从健康志愿者供体的外周血单核细胞中提取的CD8 T细胞与经LSCC-sEV处理的M0巨噬细胞共培养,以评估其增殖和免疫功能。在巨噬细胞荷瘤小鼠模型中研究LSCC-sEVs的作用。
LSCC-sEVs促进TAM的M2极化并损害CD8 T细胞功能,这归因于PD-L1表达上调。此外,抑制代谢重编程可部分逆转LSCC-sEV诱导的CD8 T细胞功能障碍。发现STC-1在LSCC-sEVs中高度富集。敲低STC1可消除TAMs向M2样巨噬细胞的代谢重编程并恢复CD8 T细胞功能。重要的是,体内结果表明,LSCC-sEVs通过介导代谢重编程将TAMs转化为M2表型并诱导CD8 T细胞功能障碍,最终加速肿瘤生长。
我们的数据揭示了LSCC-sEVs在通过STC1介导的代谢重编程调节TAMs的M2极化和免疫细胞功能方面以前未被描述的作用。